Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 6.

Journal Article

Eberwein, Philipp, Kroesser, Sonja and Steven, Philipp (2020). Semifluorinated Alkane Eye Drops in Chronic Ocular Graft-versus-Host Disease: A Prospective, Multicenter, Noninterventional Study. Ophthalmic Res., 63 (1). S. 50 - 59. BASEL: KARGER. ISSN 1423-0259

Gehlsen, Uta ORCID: 0000-0001-9057-9199, Braun, Tobias, Notara, Maria, Kroesser, Sonja and Steven, Philipp (2017). A semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eye. Graefes Arch. Clin. Exp. Ophthalmol., 255 (4). S. 767 - 776. NEW YORK: SPRINGER. ISSN 1435-702X

Steven, Philipp, Augustin, Albert J., Geerling, Gerd, Kaercher, Thomas, Kretz, Florian, Kunert, Kathleen, Menzel-Severing, Johannes, Schrage, Norbert, Schrems, Wolfgang, Kroesser, Sonja, Beckert, Michael and Messmer, Elisabeth M. (2017). Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease. J. Ocular Pharmacol. Ther., 33 (9). S. 678 - 686. NEW ROCHELLE: MARY ANN LIEBERT, INC. ISSN 1557-7732

Steven, Philipp, Braun, Tobias, Kroesser, Sonja and Gehlsen, Uta ORCID: 0000-0001-9057-9199 (2017). Influence of Aging on Severity and Anti-Inflammatory Treatment of Experimental Dry Eye Disease. Klinische Monatsblat. Augenheilkunde, 234 (5). S. 662 - 670. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-3999

Steven, Philipp, Scherer, Dieter, Kroesser, Sonja, Beckert, Michael, Cursiefen, Claus and Kaercher, Thomas (2015). Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease-A Prospective, Multicenter Noninterventional Study. J. Ocular Pharmacol. Ther., 31 (8). S. 498 - 504. NEW ROCHELLE: MARY ANN LIEBERT, INC. ISSN 1557-7732

Wirta, David L., Torkildsen, Gail L., Moreira, Helen R., Lonsdale, John D., Ciolino, Joseph B., Jentsch, Garrit, Beckert, Michael, Ousler, George W., Steven, Philipp and Kroesser, Sonja (2019). A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease. Ophthalmology, 126 (6). S. 792 - 801. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1549-4713

This list was generated on Fri Apr 23 02:41:20 2021 CEST.